Myhlth Chck Share Chat (MHC)

Will all small share holders please bend over...

Billy

I agree but she clearly was spending way more than she was bringing in.

I guess we all know why.

Let’s see what Adam brings to us.

Let’s hope FFP doesn’t become FFS which is what I thought when they announced Pennys Mutiny.

Best word for it.

I hope Adams reveals a blockbuster investment and the price doubles.

I’ll be disappointed to have missed out but will be recompense for all those who stayed the course.

Still feel gutted having been in since near the start.

Time to move over to FORF I think

MHC is finally past tense.

Fortis Frontier PLC it is. How inspiring.

Https://investors.myhealthchecked.com/corporate-news/archive/2025/101125.asp

Disposal completed

Name change

Time to move on

Adam will hopefully find a new company

Voted against.

RG

Ace

Truly I think it’s a terrible deal.

ABDX and Trls with little revenue are slowly climbing however we have products and 5m cash and a market cap of 4m.

To be honest why couldn’t Penny do a deal where

Boots invested by taking a stake in MHC etc. instead of spending over 15m of shareholders money to sell for just 2,38m

Sorry but this stock had potential and Boots know it’s a steal and I hope there’s a way shareholders can extract more from the deal but some one else will need to advise if a new offer would come if the deal is rejected.

Also would Penny still resign and would she be eligible for the bonus if it’s not sold.

I personally thought any offer would have been above 20p based on where the company is and cash still available.

The company haven’t offered any figures on margins for the new Boots own brand and any updates in early sales progress. I think Boots have made a cheap offer knowing that shareholders don’t know the margins and early sales figures.

I genuinely feel and hope shareholders can push for a better deal but I don’t know what happens if it’s rejected truly.

Could a counter offer come!.

Who truly knows but I didn’t invest to end up in a shell company but equally selling at these levels seems premature

Another great tip from the great man TW. Spent years and years pumping this on his tips website. Funny that he makes no mention of it today.

So what happens if we hold our shares?

What happens if the vote is no? (To sale)

Is there any logic in averaging down here?

Jamrock...it just wasn't with the risk now for me holding and also the time.

You never know, this may get picked up as a shell company and make a stellar acquisition of a startup which doesn't need additional costs of an IPO.

But it's all a gamble now.

It makes sense for shareholders to say no to the amount offered. But what are the consequences ?

I'm already positioning myself for a market correction.

Anyone know of any good defensive stocks for a downturn ?

The markets are way way too high for the economic data we are seeing and debt is massive.

Meanwhile FTSE is sitting near historical highs.

Probably being pressed on price. Will setttle for 11p cash ...guess Boots will take the staff.

Things are bad. Glaxo has left the UK and done a deal with Trump.

I think things are very bad with companies like this and it was this way or bankruptcy. This is what the continuous rise of gold is telling us. Todays economic figures are dire.....unemployment soaring, vacancies collapsing and so on. Oh and monster tax rises on the way.

Anyone selling now is !

Even by the price of the deal it’s around 11p.

Why sell for 6p plus.

Either way it’s a mess but can’t get my head around it. Why didn’t she fold it with 11m cash a few years ago then.

All the hard work done and a beautiful deal for Boots at shareholders expense

Also open to rival bid, lots still to unfold

Via shares in the open market to assure the vote passes.

The whole thing is a disgrace and Penny should be ashamed of herself.

Many of us who have held for a long time believed in what she said.

They have built up the portfolio and digital base for products with growth in mind.

Then partnered with Boots to sell them.

Boots have now endorsed the product by offering 2.375 million cash for a company that had over 5 million in the bank and was valued at a share price around that over 5 million.

In the release it says they have lost 1.5 million up to the end of August with revenue half that.

The only winners from this are Penny with her 176k leaving bonus for shafting everyone and her nice new job at Boots.

The value of the company is its business model and products portfolio and all that is being sold below market value after a lot of time and effort by all the employees IMO.

What will be left will be a shell company that either has to buy another company (deja vu for MHC as that was where it started), or another company buys the shell to get a market listing.

The 6 month results were late, they did no share buybacks despite resolutions at 2 AGMs, then no investor meet after last results. Where are the phlebotomy tests that were ready for market ?

Radio silence is what we got whilst Penny and the board arrange the selling of the family silver.

Angry and disappointed sums it up.....and also betrayed.

This was a large part of my portfolio and I'm not going to gamble it on a shell company. If I read it correctly, if the vote is 'no', they will delist.

I'm out as of this morning. Luckily I saw the announcement sneakily slid under the wire at 0800 instead of the usual 0700. Even that was underhand. It took me over an hour to get out of my position in chunks.

Now it is down 40% and a 33% spread.

I hope not too many were burned by this shambles.

Good luck all.

I’m not quite at all.

Assessing the info and it’s clear like everyone else has said this is a terrible deal.

The new products are selling well and the company have not offered any details on margins etc.

Hopefully it is voted against as it only benefits a few and no shareholders included.

It would be worth twice this at least if they offered details on margins etc.

Hopefully it’s voted against and Boots up the offer

A bit quiet from jamrock and his BS

Very quiet .Hmmm!

More like copious amount of egg on face maybe. You've not been quiet on advfn though 😂😂

The mm's expect buyers to pay 7.8p when they themselves are currently buying stock for around 6.1p...takes the mick

Been silent because I’m shocked.

Share holders get a terrible deal just when products bedding in. Clearly Boots get a steal only if shareholders vote for it. I personally feel it should be voted against because the company haven’t even offered margins on the products.

Lack of information is clearly to get the deal done that only benefits directors

OK - shock over - with 52.04m shares in issue then the expected cash shell of 5.7m equates to just shy of 11p a share if I've understood correctly.

I've given this company so much time and patience only to have it thrown back in my face.

After 5 years, I'm out. Liquidate whilst there is still something actually liquid.

Glad I got out last year. This is just fraud. Penny is one greedy individual imp. Good luck to all lths. Sad indictment.

Our Penny has played a blinder here... for herself. Her leaving bonus is equal to a month of operating losses of the company. So the bigger the loss concepta made, the more money she gets... talk about a lack of alignment with investors.

I wouldn't have minded a sale of the operating business to boots, but not for a pittance as it has been.

We will then be entirely relying on Adam Reynolds and co to find a suitable investment in a completely unrelated field over the next 6 months, while burning through our 5-7 million cash pile. The future is bright...

A typical Aim scandal, they are effectively giving away the operating company.

I did say last month that even though listing costs couldn't be justified as an independent, they should have merged with ABDX, so many synergies and cost savings to be had. You could pick another listed company, either way a better outcome than this. Would have counteracted the revenue falling off a cliff by immediately building scale and given shareholders chunk of a larger more sustainable and still publicly traded company.

On first examination of the RNS it appears a golden handshake/payout for the loyal, hardworking execs? Is this to be at the "funeral" of shareholders - especially loyal, hardworking and longstanding holders. Not so much a RNS rather a R.I.P. shareholder.

Will enjoy being corrected on this view

What are the implications for shareholders?

Https://www.manchestereveningnews.co.uk/news/uk-news/worrying-rise-covid-cases-across-32622932.amp

Remember most of MHCs revenue comes in the second half due to Covid rises in the winter months.

This time however we will have significant revenue from Poc doc which is also in over stores as in update so it’s fair to assume the new range of blood and LFT tests are equally in over 800 stores.

Plus MHC has the ability to expand with new products and it’s easy to see the government add some tests to pharmacy first as the winter months brings chaos to GP waiting lists.

I truly think January February will see a significant ramp up in revenue and hopefully given Boots has its own brand one would expect them to swallow the cost of the branding etc. also MHC won’t have to pay for shelf space so it’s easy to see better times ahead

JBongo

They still have over 5m in Cash!.

All the revenue from Boots blood tests will start coming through.

Poc doc revenue also.

Uptick in winter sales for Covid.

If you look at Chairman’s statement it’s clear everything is geared up for 2nd half and early 2026 for a real number crunching update.

Expect growth in high value products such as testosterone tests et. Also the iron test and vitamin D with ABDX is up for grabs shortly and I see know reason why Penny won’t box that off.

Also is there scope for more tests!

💯

I can see a blood diabetes test coming shortly

Probably because they stuck AI in the name...

Https://www.lse.co.uk/SharePrice.html?shareprice=MPAL&share=Medpal-Ai-Plc

How can a market cap of over 30m for a company that has no current revenue be acceptable when a company like MHC that has revenue and currently in growth phase be valued 5m!

Either ones over valued or one undervalued

Https://www.boots.com/flowflex-antigen-rapid-test-lateral-flow-self-testing-kit-5-tests-10312496

Can’t remember the last time over 100 were sold online in 24hr period.

Maybe the winter may bring a significant rise in sales.

So hope with new product sales and an uptick in Covid sales second half may be better.

Surely update shortly.

I have been noticing a new company to the Aim called Medpal AI.

This company is run by a very smart CEO that has run several vast growing companies or been heavily involved with such as SWC etc.

The company plans to use AI and digital health technology to revolutionise how people take care of personal health with a focus on gyms and insurance companies etc.

I would advise people to listen to the link I’m in

https://m.youtube.com/watch?v=KqPqmfRWQ3w

If MHC can do a collaboration or some kind of deal that suits both parties it would enable MHC access to millions of gym users and possibly insurance companies etc.

With tests now available such as testosterone one with Boots I strongly see huge growth.

I anticipate this sector to become a huge growth sector now the big guys have woken to the potential of digital health.

MHC with its Boots deal iis definitely in the right field.

Time to follow the big guys.

I hope Penny can and is smart enough to share news with update.

🙏🏽

Https://www.mirror.co.uk/news/uk-news/new-covid-variant-symptoms-easily-35902785?int_source=amp_continue_reading&int_medium=amp&int_campaign=continue_reading_button#amp-readmore-target

It ain’t gone but will Covid test sales increase into the winter!!!!!

Testosterone ones in Boots are doing well

Billy

£500,000 in buybacks would definitely be huge

I was just coming on here to say that.

No trades for 2 days then we get 136k, 13k,9k but more interesting is the 2 trades of 20k. MHC or institutional or a buyer building a position ?

Its not huge but relevant,

Wouldn't it be lovely if MHC put their money where their mouth is and actually utilised the resolution they passed last year and this and did some share buybacks ?

I wonder if somebody knows something.

Some. Decent buys today for the first time in ages.!

Who knows

The one really positive thing is after going on the website and typing in the availability in store for the new Boots lateral flow tests it appears they are stocked in all local Boots.

Well I typed in my postcode and all the ones near me were stocking the lFT tests which means we are available in more stores than the current MHC tests which were limited to only 500-750 stores. Boots has around 1900 stores so hopefully the revenue will show in next results.

The blood tests are currently available on the website so I’ll check local availability once they are live.

Also I note it’s clear on the blood tests they are checked by a Doctor which is positive given recent media news.

JBongo

https://www.chemistanddruggist.co.uk/news/multiples/boots-tipped-to-work-with-neighbourhood-health-hubs-U3RSOYXXHFDXZHLG4SLYOP4KOI/

You have to look at the tests and wonder are they geared up and designed to be added to pharmacy first. The recent deals MHC have done and Boots also featuring the MHC trade mark and name demonstrates a wider plan.

I feel everything is geared for both patients and private customers to access the NHS data base with results is part of a wider plan.

Interesting to see how launch goes and advertising with it.

I’d love to know who’s fitting the costs for the packaging etc.

More financial details would have helped imo.

Nevertheless a positive move by MHC who must feel confident in Boots plans and its own ability to grow to adopt a strategy like the one taken.

I still believe the lagging share price could hamper expansion for MHC unless they enact a plan to increase share price.

Maybe a buyback would help the falling share price

The types of tests look very similar to the MHC branded ones. I wonder if these MHC ones will disappear from Boots online and physical stores now, given the crossover with the new products. Think the packaging is nicer on the MHC branded ones tbh. But I guess people trust Boots more than MHC whatever the packaging looks like.

One new product I can see is the testosterone test. Good to see as I was looking for one recently and had to go with a competitor as MHC didn't have one available.

I guess the margins will be tighter on the new products, but hopefully higher volume.

Https://www.boots.com/sitesearch?searchTerm=Boots+blood+test+kit

The packaging and fact they have My health checked plastered over them demonstrates Boots alliance is strong.

Also they appear to be starting with a 20% discount.

Very reasonably priced

Nice looking packaging.

Interesting to see if a advertising campaign starts with

It.

Https://retailtimes.co.uk/boots-expands-at-home-testing-kit-range-to-help-the-nation-get-a-better-understand-their-health-without-the-waiting-lists/

So we now know the tests

Any opinions!

What people are are missing is that before it cost Boots millions in shelf design and space in 500 stores when it initially launch its products in Boots.

Now MHC products will potentially be in all major stores and cities with nearly Boots having nearly 2000 stores. The revenue stream is huge and potential massive.

Boots need to announce details imminently given the intended launch is August.

The details will be the key to share price moving.

Definitely time to get this share moving

This week is a big one given the AGM .Also given we are moving into August shortly and Penny announced plans for new tests release in Boots.

I would hope given last week’s negative news regarding LFT tests that Boots anMHC would jointly make it clear that its tests are often analysed by the same labs used by the NHS.

I feel what Boots and MHC are about to do is going to plant the strategy to relieve the NHS of its stresses from an outdated system whereby many patients have to wait weeks to see a GP.

Boots and MHC could truly become market disrupters and anyone not seeing the importance of this in savaging million s for the NHS need to seriously look again.

Then we have private care side and potentially for large companies like Amazon etc who know sending employees for regular checks is both tax deductible and beneficial to the employer who can help prevent lost work hours with paid checks in places like Boots.

Boots is definitely putting plans in place and Wes Streeting has been side tracked due to the junior Doctors strike.

The NHS needs change and MHC definitely a part of that change.

I’m guessing we will still have at least 3.5m in the bank and continue to be self funded as revenue flows from the new tests especially if any are added to pharmacy first.

Happy days ahead I think

Good luck all holders

Jamrock,

I totally agree many of "us longtimers" have followed the company development since Uncle Eric and the original Concepta "shell company" infancy. I was alarmed at hearing/reading the report and hope that Penny and the board robustly challenge the report and recruit Boots etc. to champion regulated products as supplied by MHC. The NHS is changing and with many folk struggling for GP appointments the safe, regulated options now available via companies like MHC potentially have a strong future enhancing not diminishing the GP/NHS structure

Please note Pennys response to GMb report which was issued via her PR team under CONCEPTA .

The news today that at-home tests or ‘off-the-shelf health tests’ may be unfit for purpose is misleading.

The information published today in the British Medical Journal refers specifically to direct to consumer self-test devices, such as lateral flow tests, whereas at-home or ‘off-the-shelf health tests’ also include testing formats such as sample collection kits, that are then sent away to a laboratory and are robustly tested with result provided in the form of a report.

Laboratory tests such as those provided by MyHealthChecked, do not require lay-person interpretation, and do not carry risks of false positives or negatives which can be associated with lateral flow devices. Selected laboratory partners are typically ISO 15189 accredited, and in many cases, process thousands of NHS tests annually.

It’s disappointing and misleading for the end user to see the lines between the different at-home tests blurred, when the study and publication refers to direct-to-consumer self-tests only. The NHS is under significant pressure, and the general public is often keen to explore robust testing practices to aid their knowledge and help them to make informed decisions.

Rapid tests like LFTs are designed to be screeners: customers can quickly check for health issues, and take concerns further with a doctor if necessary. For those wanting a more in-depth report, laboratory tests provide NHS-standard analysis and expert recommendations that leave little room for doubt.

At-home testing does not seek to replace the role of a GP, or provide additional workload, but it can provide a means for customers to understand their own health biomarkers, and make informed decisions.

Penny McCormick

Chief Executive Officer

I feel Penny should personally ask GMB for an opportunity to see the record straight because MHC is both compliant and working to help the NHS and should be commended for its good work and tests.

GMB have been mis leading according to the words of Penny our CEO

Rob

Newfoundland provides MHC with LFT tests and HIV test also.

There tests are 99% plus accurate.

https://www.google.com/search?q=are.new.foundland.tests+regulated&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari

I think clarification from either or both parties would cement MHC and demonstrate there commitment to regulation approved products

Time for the spread to narrow and give it a chance to run

I wonder if the seller yesterday has more left to sell.

Think yesterday was bad timing for seller

Https://www.lse.co.uk/news/TRLS/trellus-health-shares-soar-on-collaboration-with-johnson-johnson-wg8o73udilpg178.html

Penny has close links to the board of Trls due to work at previous companies.

Should Penny use her influence and position to do a deal with Trls who are clearly in need of a deal to allow its technology to access NHS patients.

Bowl conditions are extremely common and definitely an area Penny should consider in her plans.

Given the change in people’s diet etc over years bowl conditions has also risen.

Maybe an opportunity for another collaboration in my opinion.

JBongo

Note the bit about care homes etc.

What this does is underscores the confidence in the MHC technology. It also puts MHC in the minds of patients. I believe Boots will reveal the true meaning of today’s deal and I feel our products will be on the pharmacy first list soon.

GPs lists are costing NHS millions in missed appointments etc and there are many who can’t even get one.

Time for patients to be able to self test and upload personal information to personal records on the NHS

Yes the launch next month by boots will be interesting. Hopefully lots of advertising by them.

Today's announcement doesn't seem as big to me tbh. It just looks like a way for customers to get their own results and then upload them somewhere else. I'm not sure how that makes us more money.

Https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=MHC.L

Are British bull correct.

Who knows!.

We need Wes Streeting to up his game blue print plans for pharmacies and patients care.

How many stores will these tests be in.

The one positive is that MHC won’t have to pay for shelving like they did with own brand.

Remember Penny is also learning as the data comes in.

Time for Directors to buy!

Hot chip

No it’s not a case of just labelling existing tests. MHC has registered phlebotomy tones phlebotomy tests recently. We haven’t had any details of what these tests are which makes it more exciting.

MHC has clearly realised Boots will push tests in their own label first. Then there’s pharmacy first which could play a roll in bringing down NHS waiting lists. If any of these tests make it onto to pharmacy first then NHS patients can have the tests paid for by the NHS. It’s clear that the government is rolling out care in the community and there no Better pharmacy other than Boots which is making it’s services and products available to patients..

Between MHC, Boots and others like ABDX the government plans to utilise these facilities to transform patients experience, save money in GP appointments and waiting times.

The landscape is moving from sitting in a waiting room in GPs waiting area to the convenience of places like Boots.

MHC has invested millions in Digital Data and compliance regulation so they clearly share the vision of the government changes coming.

Boots will probably do an advertising campaign soon I guess. Hopefully TV to get the message across they are ready for the public both private and NHS patients.

ABDX labels iron and vitamin D tests for Boots and upon this announcement last year there share rocketed way more than we have.

Also remember MHC hasn’t diluted share holders value.

It’s impossible to give numbers because I believe government changes could be huge and until they start next month Boots and MHC don’t really know how the service will go down. One thing is sure 💯. The NHS and patients experience will be changing for the good whilst waiting lists falling.

No numbers. Also, aren't they just white-labling tests that were originally under the MHC brand, for sale in Boots? I just don't see how this makes any difference, unless the view is that Boots-branded tests will see more than MHC-branded tests....

DYOR

Https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-thursday-17th-july-2025/

Could 20p be on the cards as Zak believes.

I guess it depends on whether we have a decent finish.

Given news f this deal was over due I’m surprised the we tested lows recently.

Hopefully now we get a bit positive momentum as the tests are revealed!.

What will they be!.

Will any be added to pharmacy first.

I’ve long said we should be testing for cancer in Boots but given it’s a sensitive subject I guess that’s the problem.

Reveal the tests.

Also when is the contract renewal for iron and vitamin D tests ABDX won last year.

I suspect MHC may go after that one also

Remember this went to 21p on news of phlebotomy testing was on the way.

It’s now arrived!.

We don’t even know what’s the tests are.

This alone could be significant.

Whatever this marks a significant change in Covid dependence revenue.

My tells me this will be much higher soon especially as the AGM is weeks away.

It will interesting to see if Penny and the board are clear to buy at the AGM

Spin

Even with today’s rise I suspect most still way down and never topped up.

I say that because this was falling daily on extremely low volumes.

Hopefully now if momentum kicks in we can see a meaningful slow rise.

Have to say I did expect this to push North up 17p today but I guess that was me wishful thinking.

However the charts are indicating we could see a test of 17p and a breakthrough would see 25p quicker than we think.

Again only if we have a follow through.

News from the board confirming how many stores these test going to be in and what the tests are.

Today was still a nice uplifting day but more needed for people to really get excited.

ABDX did a huge rise after it announced two tests over a year ago. Iron and vitamin D ones.

So this deal should truly value MHC above the 25p mark given they have achieved so much without any capital raises.

5,5m in Bank at the end of 2024!

Revenue from Poc Doc and HiIV tests to start showing up on the books.

Downside is slowing Covid revenue but let’s hope these new tests prove the strategy is working.

I wonder if Boots will advertise these tests soon!

Well done. Good luck today. You deserve it. Have a lie in..

Bought in here first thing - so quite happy right now - the company should see quite an increase in their turnover especially if chemists do more front line testing and I'm sure there is sufficient margin to make both parties happy.

What's wrong with Walbrook? I quite like PM ....

gla

I tested positive for Covid today.

I already had a test kit available here but went to boots to get some so other half could be tested (she tested positive too).

I noted that the MHC display and shelves underneath were both empty/out of stock.

For that particular Boots it is not unusual as their stock levels are always shocking.

My other half usually ends up having to go to a much bigger boots (even though the one mentioned is already large on a retail park) to get her supplies.

Point is, Boots are not good at maintaining stock levels.

This might seem a strange thing to say but this share has been falling months on very low sales each day however both yesterday and today we have seen a couple of decent buys and no share movement!.

Is some filling a large order at these low prices.

Can we expect a RNS to coincide with the AGM of a buyer.

Maybe a Director or probably it could be Donald or Stephen!.

It just my personal observation but this seems a strange pattern to me

MHC ready to roll out phlebotomy tests.

Over 5m in the Bank at end of 2024.

New revenue from Pic Doc and HIV tests.

Negative is slowdown in Covid sales.

Can the board turn sales around . My guess is it would be good if MHC could have produced a test that was added to pharmacy fist list.

It’s a difficult challenge but one that can still yield results for MHC.

With a RSI of 10 I personally feel it’s well undervalued given both cash position and fact it’s not diluted shareholder value over the years.

However the markets control the price but MHC releasing phlebotomy tests and launch date could be a great help to change sentiment.

Good luck holders

Spindok

Many people are investing in companies like QBT without any revenue. They pin there hopes on future revenue streams. MHC do actually have revenue and working products etc.

For the record I also have a small investment in QBT but nothing of significance.

MHC can gain traction from investors if they present a convincing deal with Boots along with a plan that demonstrates real long term sustainable growth.

I feel Penny is the right person however I feel her hands are tied by Boots who in return are probably waiting for the government plans for health in the community.

https://www.gov.uk/government/news/pm-launches-new-era-for-nhs-with-easier-care-in-neighbourhoods#:~:text=Prime%20Minister%20launches%20government's%2010,care%20plans%20for%20complex%20needs

Pharmacies are definitely going to play a part and as I right this it’s being discussed on sky news etc

I think they have enough cash to see this through to the beginning of the upturn... Sadly though they have lost a lot of shareholders from boredom ..

The chart is at a critical point

Time for news and a swift move upwards in my opinion

Tef

It really could have been a lot worse given the figures they gave us for the half year results.

As I keep saying we need to focus on new product growth.

I actually feel we held up well on low volume so investors staying strong.. large share holders sitting tight.

Any news and she moves but as and when is a different story.

I’m not selling and considering buying once it settles

Nothing hugely exciting in the results, transition away from covid revenue continues and loss reflects that. Needs to regular new on products and partnerships to get some upward movement. I worry that we will now hear nothing further. Less than expected VAT refund which was a little disappointing.

Phlebotomy testing and a deal with Boots is the key to MHCs future.

Https://investors.myhealthchecked.com/docs/librariesprovider66/archive/results/prelims-2024.pdf

I guess in MHCs defence you can only communicate a deal if the other parties are happy to sign it off. I guess the fact the focus is on Boots and Pharmacy 2U they clearly have plans for a deal that gives greater access to NHS customer base.

It’s definitely sad to see it fall but shares go up and down. In fact in real terms they ain’t that far off all times lows.

Crazy when other stocks without cash rise

I cannot understand why companies never learn. They rise and fall on good communication. This lot do not even communicate. Have only a few in an isa which would not be worth selling.

Https://m.youtube.com/watch?v=VdouJ9AgkEE&pp=0gcJCdgAo7VqN5tD

Not saying new variant will seriously impact the UK but equally any new variant can add to revenue for Covid tests.

If new tests sell well while Covid revenue continues then MHC will remain self funded while expanding.

New Poc revenue should hit the market soon in Boots when plans announced

Tef

I’m quietly confident results will be In a few weeks.. I feel Penny is being as transparent as she possibly can given they are probably locked

Into negotiations. However it’s equally frustrating because shareholders value is drifting lower with the wait for news .

The lack of news is again anchoring the value down well below where it should be and it is the question I asked at the last shareholder meeting. More a point about the lack of news and updates being an issue for shareholder value. it was replied to about not being able to share updates about ongoing negotiations which didn't really answer the point I was making.

The longest it can be dragged out, I think, without breaking AIM rules will be the end of June for full year results. Again not even stating the results date leads to "worries" about corporate governance and the 'value' being given to shareholders.

Currently continuing to hold but will be selling if we get back to 20p as I can't continue to put up with the lack of updates or communication.

The market makers are having a field day with this. Yesterday you could sell £14,000 @ 11.27p and today you can only sell a couple of grand for 11.15p.

Someone trying to create fear. My opinion is holders should hold on for results and maybe add on good sales in the likes of HIV tests which is helping compensate for any covid revenue decline. Fact is markets are forward looking for life after covid.

Come on Penny release the results date please and let’s all get an insight into things and plans

Expecting results within a few weeks and an update to inform us of plans for roll out of phlebotomy tests and Poc Doc. This will be significant to future revenue if plans with Boots are shared also.

Government cuts everywhere in the NHS to save money however if MHC and Boots can save NHS costs then it’s a win win. Just my opinion.

In the meantime anything possible with the share price as markets waiting for news.

My initial thoughts are we have a lot of revenue from HIV tests however a decline in covid tests which is expected. That said a new strain sweeping America and Europe which has lifted NCYT shares so if this develops further it could bring in move revenue for MHC. MHC has secured 3m test sales within Boots at last update so revenue and Balance should be steady.

News on Poc doc also.

I am quietly optimistic that sales of over 1m in HIV tests alone could easily be achieved or more depending on instore sales.

Exciting times for MHC but board need to be upfront with plans and guidance to reassure the markets.

I am shocked however POC DOC details haven’t been released.

Also could pharmacy 2U be a pleasant surprise!.

Once again short term markets are hammering the share for lack of information but equally they will get behind it if plans are shared at results.

It’s in Penny’s hands but equally many LTHs are losing a lot so something positive will be welcome news

Https://www.boots.com/myhealthcheck-vitamin-d-rapid-test-10322820

Great to see the Vitamin D test back online. It’s been a top seller at the moment for Boots own brand and good to see MHC back in the frame.

Just waiting for trading update and hopefully the journey continues onwards and upwards

Blessings

Crazy how price drops on little share sales but goes up slowly when decent buys.

That said think the market is clearly waiting for news to judge us.

After watching the program you see Boots got a great shout out with its product labelled by ABDX. Surprising that MHC didn’t win the contract for Boots own Brand.

I guess they will go after it again. Seems strange how Boots chose ABDX over MHC for the vitamin D and Iron tests.

Surely the results must be prepared!.

The hold up must be just with news pending

Https://m.youtube.com/watch?v=mt8BjoZfhVQ

Think this is the link.

A great advertisement really however we need more clarity about plans moving forward I think. We all expected a trading update and I personally want to see deals etc announced with Trading update.

Share price falling back on low volume but hopefully a good Trading Statement will change this.

Interesting to see if large shareholders up stakes on any pull back.

MyHealthChecked, along with other brands, were featured on ITV's This Morning... this morning. I haven't watched the segment but have seen this LinkedIn post about it.

Stay at home mums, housewives & retirees are the core demographic of the program and undoubtedly this will drive a few sales.

linkedin.com/company/myhealthchecked-plc/posts?lipi=urn%3Ali%3Apage%3Ad_flagship3_feed%3BIFsagfh6QKCNLIgKzYRCwQ%3D%3D

Why is the trading update so late compared to last year which was 11th January!

I guess news is coming with the statement.

Prime minister taking a HIV test!

I guess he’s endorsing testing at home

Watch this space

Boots on the ground needed

Let’s get the deal done

Can someone explain why the vitamin D test has been off sale online for many months. Allowing Boots own brand which is supplied by ABDX to take all online sales. MHC has a 20% discount however vitamin D sales for Boots sales are still strong. Surely this must be addressed

Https://uk.linkedin.com/company/myhealthchecked-plc

Poor Health costs Businesses 138 billion each year!

Wow!!!!

Is this MHC saying they want piece of the market.

B2B and deals with large organisations on the way!.

I think something big coming and BOOTS on the ground in shopping centres will be needed.

Delayed trading statement to coincide with a deal possibly.

Is Penny creating something huge in MHC.

Will NCYT take them out first.

Watch this space!

Amazing given the situation with the NHS we ain’t featured in more national news papers

Party just starting

Watch selling price move to 17p

No stock

When more announcements come this will double in my opinion

Hi Jamrock

09.29 I just did a deliberate buy of 7825 @ 15,45 and not showing anywhere!

not too concerned like you been in this baby since I was in junior school!!

No stock available in large chunks and so I see 20p coming rapidly as demand ramps up

So strange you can’t get a live price on £2,000 worth to buy and can sell £10,000 at 15.44p!

Is this demonstrating signs of a short squeeze and a possible breakout

Don’t want to call it but looks that way

Stephen and Donald sitting in a tree, b.u.y.i.n.g...

Well done...

Https://theindustry.beauty/boots-sales-rise-thanks-to-record-breaking-black-friday/

So pharmacy first figures in!

So is guidance for positive covid sales upto End November.

Remember HIV tests doing well.

30 stores refurbished!

Focus on digital data.

“In healthcare, comparable pharmacy sales were up 10.9%, primarily driven by continued strong performance in services including flu, COVID-19 and travel vaccinations.”

I hope we understand why MHC is focusing on Boots plans.

Hopefully plans for MHC expansion with Boots will be revealed with positive update due soon!

Https://www.gov.uk/government/news/power-to-patient-as-government-sets-out-plan-to-cut-waiting-lists

So plan for Community Diagnostics Centre in town centres . I guess it’s logical and reasonable to assume they mean Boots in collaboration with MHC.

PM sets out plan to tackle hospital backlog

"More NHS hubs will be set up in community locations and there will be greater use of the private sector to help reduce hospital waiting lists in England, the prime minister has said.

Sir Keir Starmer also promised patients more choice over where they are treated, as he unveiled plans to tackle the NHS backlog."

"The plan includes:

expanding the network of community diagnostic centres and surgical hubs, to enable more treatment outside of hospitals

making it easier to exercise patient choice - this was introduced 20 years ago but only one out of every four patients believes they are offered a choice of where they are treated

a new deal with the independent sector so more NHS patients can be treated in private clinics, with a particular emphasis on joint operations and gynaecological procedures"

"Sir Keir said: "NHS backlogs have ballooned in recent years, leaving millions of patients languishing on waiting lists, often in pain or fear, lives on hold, potential unfulfilled.

"This elective reform plan will deliver on our promise to end the backlogs.

On expanding use of the private sector, Sir Keir acknowledged "some would not like this" but added: "I'm not interested in putting ideology before patients.""

Boots are in the best position to help deliver this and MHC diagnostic tests can play a part given the ISO compliance accreditation and emphasis on digital data.

Ask why MHC are keen on POC DOC deal and Boots contract.

I guess Penny will reveal all soon but if you read Chairman’s joint statement you’ll note he state that they hoped to share news soon regarding phlebotomy testing plans.

I personally see a positive update.

Increase in new product sales ( HIV) test example.

More collaborations or takeover!

Strong cash flow and growth.

Deal with Boots becoming stronger

VAT refund to strengthen Books.

Large investors increasing holdings

Share price prediction

I see today’s move as a possible breakout of 6 month downside. Potential upside 15-17p then if news due this month is positive who knows. We need clarification on deals to evaluate possible revenue and profit.

Whats your best guess jamrock?